Literature DB >> 21892136

Obesity: Orlistat 60 mg reduces levels of visceral adipose tissue in obese individuals.

Isobel Franks.   

Abstract

Entities:  

Year:  2011        PMID： 21892136     DOI： 10.1038/nrgastro.2011.128

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.

Authors:  Steven R Smith; Kaj S Stenlof; Frank L Greenway; John McHutchison; Susan M Schwartz; Vidhu B Dev; Evan S Berk; Roxanne Kapikian
Journal:  Obesity (Silver Spring)       Date:  2011-06-30       Impact factor: 5.002
  1 in total
  1 in total

1.  Design, development and optimization of self-microemulsifying drug delivery system of an anti-obesity drug.

Authors:  Jagruti Desai; Nirav Khatri; Sachin Chauhan; Avinash Seth
Journal:  J Pharm Bioallied Sci       Date:  2012-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.